Drug developed by AI gets first human trials
An artificial intelligence created by a collaboration between British firm Exscientia and Japanese pharmaceutical company Sumitomo Dainippon Pharma has developed a drug that is going to enter the first phase of human trials in Japan. The drug is a treatment for those suffering from Obsessive Compulsive Disorder, and while human-engineered drugs take up to five years to develop, the AI took only a year to engineer the medicine.
uk japan ai trial british drug human pharmaceutical artificial-intelligence exscientia sumitomo-dainippon ocd obsessive-compulsive-disorder
BBCRelated Articles
Japanese flu medicine helps against coronavirus, Chinese officials say
Chinese medical officials have stated that they treated 340 coronavirus patients with the Japanese flu medication called favipiravir, which helped in reducing the time the virus infects the body and also improved lung condition in patients. Patients treated in Wuhan, the epicenter of the coronavirus, recovered from the illness in about 4 days as compared to 11 days for patients not treated with favipiravir.
china japan recovery medical coronavirus wuhan patient lungs pandemic treatment covid-19 symptoms flu favipiravir
NewYorkPost
Malaria medication could be a cure for coronavirus, research finds
Researchers led by infectious disease expert Didier Raoult have found that the drug hydroxychloroquine, used in the treatment of malaria, could potentially be a cure for the novel coronavirus, with a lab experiment involving 26 patients revealing more than 50 percent of coronavirus-positive patients tested negative for COVID-19 after a week of treatment with hydroxychloroquine.
research negative experiment disease drug medication positive cure coronavirus infectious treatment covid-19 didier-raoult hydroxychloroquine
WashingtonExaminer
Millions of asthma patients in the UK at risk due to coronavirus
Following UK's Conservative Prime Minister Boris Johnson's announcement asking those who were vulnerable to the COVID-19 infection to stay at home for a minimum of 12 weeks, the country's asthma association Asthma UK has questioned how the briefing applies to the 5.4 million asthma patients in the UK, who may experience seriously aggravated asthma symptoms if they contract the coronavirus infection.
uk conservative prime-minister boris-johnson association condition infection coronavirus covid-19 symptoms asthma
HuffingtonPost
Scientists use revolutionary new AI to create powerful antibiotic
Senior researchers at the Massachusetts Institute of Technology (MIT) have created a powerful AI that can analyze one hundred million chemical compounds in a matter of days. They then used this AI to create the most powerful antibiotic that has ever been discovered. This breakthrough will help scientists keep up with bacteria that become resistant to medicine over time.
science medicine healthcare ai artificial-intelligence antibiotic
BBC